Crizotinib may increase the QTc-prolonging activities of isoflurane.


Ivabradine may increase the QTc-prolonging activities of cisapride.


granisetron may increase the QTc-prolonging activities of mifepristone.


Dofetilide may increase the QTc-prolonging activities of clozapine.


Gemifloxacin may increase the QTc-prolonging activities of Degarelix.


droperidol may increase the QTc-prolonging activities of histrelin.


chloroquine may increase the QTc-prolonging activities of alfuzosin.


chloroquine may increase the QTc-prolonging activities of protriptyline.


quetiapine may increase the QTc-prolonging activities of diphenhydramine.


Paliperidone may increase the QTc-prolonging activities of olanzapine.


Flupentixol may increase the QTc-prolonging activities of sulfisoxazole.


Gemifloxacin may increase the QTc-prolonging activities of Mirabegron.


Zuclopenthixol may increase the QTc-prolonging activities of clomipramine.


ofloxacin may increase the QTc-prolonging activities of Eribulin.


Lenvatinib may increase the QTc-prolonging activities of promazine.


disopyramide may increase the QTc-prolonging activities of clomipramine.


promazine may increase the QTc-prolonging activities of Degarelix.


dolasetron may increase the QTc-prolonging activities of Eribulin.


flecainide may increase the QTc-prolonging activities of foscarnet.


clarithromycin may increase the QTc-prolonging activities of DESFLURANE.


PROCAINAMIDE may increase the QTc-prolonging activities of PRIMAQUINE.


Perfluoropropane may increase the QTc-prolonging activities of Mirabegron.


Dronedarone may increase the QTc-prolonging activities of Eribulin.


Lumefantrine may increase the QTc-prolonging activities of Degarelix.


ofloxacin may increase the QTc-prolonging activities of LEVOFLOXACIN.


sotalol may increase the QTc-prolonging activities of moxifloxacin.


PRIMAQUINE may increase the QTc-prolonging activities of maprotiline.


Iloperidone may increase the QTc-prolonging activities of Pazopanib.


Lumefantrine may increase the QTc-prolonging activities of MOEXIPRIL.


Lumefantrine may increase the QTc-prolonging activities of tizanidine.


Lumefantrine may increase the QTc-prolonging activities of protriptyline.


Vemurafenib may increase the QTc-prolonging activities of Eribulin.


Lumefantrine may increase the QTc-prolonging activities of alfuzosin.


sotalol may increase the QTc-prolonging activities of tolterodine.


granisetron may increase the QTc-prolonging activities of droperidol.


Gemifloxacin may increase the QTc-prolonging activities of olanzapine.


Gemifloxacin may increase the QTc-prolonging activities of methadone.


azithromycin may increase the QTc-prolonging activities of Vorinostat.


droperidol may increase the QTc-prolonging activities of Vardenafil.


Asenapine may increase the QTc-prolonging activities of alfuzosin.


Bedaquiline may increase the QTc-prolonging activities of Gemifloxacin.


Bedaquiline may increase the QTc-prolonging activities of desipramine.


methadone may increase the QTc-prolonging activities of olanzapine.


methadone may increase the QTc-prolonging activities of trimethoprim.


Panobinostat may increase the QTc-prolonging activities of Treprostinil.


quinidine may increase the QTc-prolonging activities of Sunitinib.


propafenone may increase the QTc-prolonging activities of Octreotide.


ondansetron may increase the QTc-prolonging activities of trazodone.


disopyramide may increase the QTc-prolonging activities of nicardipine.


Escitalopram may increase the QTc-prolonging activities of Arformoterol.


citalopram may increase the QTc-prolonging activities of famotidine.


chloroquine may increase the QTc-prolonging activities of Fingolimod.


propafenone may increase the QTc-prolonging activities of Eribulin.


Nilotinib may increase the QTc-prolonging activities of nortriptyline.


Telavancin may increase the QTc-prolonging activities of promazine.


fluoxetine may increase the QTc-prolonging activities of ritonavir.


Nilotinib may increase the QTc-prolonging activities of amoxapine.


quinidine may increase the QTc-prolonging activities of Panobinostat.


clozapine may increase the QTc-prolonging activities of imipramine.


moxifloxacin may increase the QTc-prolonging activities of Voriconazole.


Lumefantrine may increase the QTc-prolonging activities of foscarnet.


Dofetilide may increase the QTc-prolonging activities of Salmeterol.


Telithromycin may increase the QTc-prolonging activities of maprotiline.


granisetron may increase the QTc-prolonging activities of histrelin.


arsenic trioxide may increase the QTc-prolonging activities of terbutaline.


pimozide may increase the QTc-prolonging activities of mifepristone.


Paliperidone may increase the QTc-prolonging activities of MOEXIPRIL.


Pazopanib may increase the QTc-prolonging activities of felbamate.


Ziprasidone may increase the QTc-prolonging activities of amitriptyline.


moxifloxacin may increase the QTc-prolonging activities of DESFLURANE.


granisetron may increase the QTc-prolonging activities of Perfluoropropane.


ondansetron may increase the QTc-prolonging activities of Bortezomib.


promazine may increase the QTc-prolonging activities of MOEXIPRIL.


methadone may increase the QTc-prolonging activities of histrelin.


promazine may increase the QTc-prolonging activities of tizanidine.


Asenapine may increase the QTc-prolonging activities of Sunitinib.


fluoxetine may increase the QTc-prolonging activities of sertraline.


quetiapine may increase the QTc-prolonging activities of Sunitinib.


disopyramide may increase the QTc-prolonging activities of maprotiline.


Gadobenic acid may increase the QTc-prolonging activities of Sunitinib.


Gadobenic acid may increase the QTc-prolonging activities of Posaconazole.


moxifloxacin may increase the QTc-prolonging activities of sevoflurane.


ondansetron may increase the QTc-prolonging activities of formoterol.


moxifloxacin may increase the QTc-prolonging activities of metoclopramide.


TETRABENAZINE may increase the QTc-prolonging activities of felbamate.


moxifloxacin may increase the QTc-prolonging activities of Aripiprazole.


Telavancin may increase the QTc-prolonging activities of granisetron.


haloperidol may increase the QTc-prolonging activities of isoflurane.


Perfluoropropane may increase the QTc-prolonging activities of doxepin.


PROCAINAMIDE may increase the QTc-prolonging activities of Bedaquiline.


anagrelide may increase the QTc-prolonging activities of chloroquine.


clarithromycin may increase the QTc-prolonging activities of lithium ion.


Crizotinib may increase the QTc-prolonging activities of ritonavir.


Crizotinib may increase the QTc-prolonging activities of haloperidol.


LEVOFLOXACIN may increase the QTc-prolonging activities of fluconazole.


LEVOFLOXACIN may increase the QTc-prolonging activities of erythromycin.


sotalol may increase the QTc-prolonging activities of TRIPTORELIN.


Flupentixol may increase the QTc-prolonging activities of norfloxacin.


anagrelide may increase the QTc-prolonging activities of Gadobenic acid.


methadone may increase the QTc-prolonging activities of felbamate.


promazine may increase the QTc-prolonging activities of alfuzosin.


promazine may increase the QTc-prolonging activities of protriptyline.


PROCAINAMIDE may increase the QTc-prolonging activities of doxepin.


Escitalopram may increase the QTc-prolonging activities of felbamate.


moxifloxacin may increase the QTc-prolonging activities of protriptyline.


Perfluoropropane may increase the QTc-prolonging activities of nortriptyline.


moxifloxacin may increase the QTc-prolonging activities of alfuzosin.


Zuclopenthixol may increase the QTc-prolonging activities of trazodone.


Telavancin may increase the QTc-prolonging activities of clarithromycin.


Quinine may increase the QTc-prolonging activities of moxifloxacin.


goserelin may increase the QTc-prolonging activities of Degarelix.


Artemether may increase the QTc-prolonging activities of amitriptyline.


sulfisoxazole may increase the QTc-prolonging activities of amantadine.


haloperidol may increase the QTc-prolonging activities of Atomoxetine.


ELIGLUSTAT may increase the QTc-prolonging activities of tolterodine.


Quinine may increase the QTc-prolonging activities of promethazine.


Crizotinib may increase the QTc-prolonging activities of sertraline.


haloperidol may increase the QTc-prolonging activities of venlafaxine.


Nilotinib may increase the QTc-prolonging activities of TRIPTORELIN.


flecainide may increase the QTc-prolonging activities of granisetron.


haloperidol may increase the QTc-prolonging activities of thiothixene.


disopyramide may increase the QTc-prolonging activities of droperidol.


Telavancin may increase the QTc-prolonging activities of methadone.


disopyramide may increase the QTc-prolonging activities of imipramine.


dolasetron may increase the QTc-prolonging activities of chloroquine.


Nilotinib may increase the QTc-prolonging activities of thiothixene.


toremifene may increase the QTc-prolonging activities of propofol.


trazodone may increase the QTc-prolonging activities of Lopinavir.


ciprofloxacin may increase the QTc-prolonging activities of isradipine.


clozapine may increase the QTc-prolonging activities of Salbutamol.


sotalol may increase the QTc-prolonging activities of Indacaterol.


PRIMAQUINE may increase the QTc-prolonging activities of Arformoterol.


azithromycin may increase the QTc-prolonging activities of nicardipine.


azithromycin may increase the QTc-prolonging activities of desipramine.


Paliperidone may increase the QTc-prolonging activities of Octreotide.


Lumefantrine may increase the QTc-prolonging activities of isoflurane.


clozapine may increase the QTc-prolonging activities of Sunitinib.


Flupentixol may increase the QTc-prolonging activities of goserelin.


ondansetron may increase the QTc-prolonging activities of moxifloxacin.


anagrelide may increase the QTc-prolonging activities of Panobinostat.


Lenvatinib may increase the QTc-prolonging activities of trazodone.


disopyramide may increase the QTc-prolonging activities of norfloxacin.


Lopinavir may increase the QTc-prolonging activities of Arformoterol.


disopyramide may increase the QTc-prolonging activities of ondansetron.


chloroquine may increase the QTc-prolonging activities of maprotiline.


pimozide may increase the QTc-prolonging activities of nicardipine.


Paliperidone may increase the QTc-prolonging activities of Eribulin.


chloroquine may increase the QTc-prolonging activities of Salmeterol.


TETRABENAZINE may increase the QTc-prolonging activities of desipramine.


TETRABENAZINE may increase the QTc-prolonging activities of Gemifloxacin.


disopyramide may increase the QTc-prolonging activities of OLODATEROL.


ondansetron may increase the QTc-prolonging activities of Treprostinil.


Perfluoropropane may increase the QTc-prolonging activities of Pasireotide.


sotalol may increase the QTc-prolonging activities of indapamide.


toremifene may increase the QTc-prolonging activities of doxepin.


clozapine may increase the QTc-prolonging activities of azithromycin.


Iloperidone may increase the QTc-prolonging activities of thiothixene.


erythromycin may increase the QTc-prolonging activities of Salbutamol.


Ivabradine may increase the QTc-prolonging activities of pimozide.


Ibutilide may increase the QTc-prolonging activities of Bortezomib.


Gemifloxacin may increase the QTc-prolonging activities of imipramine.


Dofetilide may increase the QTc-prolonging activities of Gadobenic acid.


ciprofloxacin may increase the QTc-prolonging activities of Fosphenytoin.


Gemifloxacin may increase the QTc-prolonging activities of droperidol.


Lopinavir may increase the QTc-prolonging activities of TRIPTORELIN.


PRIMAQUINE may increase the QTc-prolonging activities of amitriptyline.


cisapride may increase the QTc-prolonging activities of trimipramine.


Ibutilide may increase the QTc-prolonging activities of droperidol.


sulfisoxazole may increase the QTc-prolonging activities of mefloquine.


TETRABENAZINE may increase the QTc-prolonging activities of azithromycin.


Artemether may increase the QTc-prolonging activities of famotidine.


Nilotinib may increase the QTc-prolonging activities of Atomoxetine.


propafenone may increase the QTc-prolonging activities of apomorphine.


Pazopanib may increase the QTc-prolonging activities of Gemifloxacin.


propafenone may increase the QTc-prolonging activities of Ibandronic Acid.


Zuclopenthixol may increase the QTc-prolonging activities of granisetron.


SAQUINAVIR may increase the QTc-prolonging activities of Degarelix.


Ibutilide may increase the QTc-prolonging activities of Pazopanib.


Lopinavir may increase the QTc-prolonging activities of terbutaline.


Artemether may increase the QTc-prolonging activities of Degarelix.


clarithromycin may increase the QTc-prolonging activities of Arformoterol.


Asenapine may increase the QTc-prolonging activities of tamoxifen.


Asenapine may increase the QTc-prolonging activities of galanthamine.


Lenvatinib may increase the QTc-prolonging activities of Vardenafil.


ofloxacin may increase the QTc-prolonging activities of felbamate.


Nilotinib may increase the QTc-prolonging activities of isoflurane.


Ibutilide may increase the QTc-prolonging activities of ciprofloxacin.


propafenone may increase the QTc-prolonging activities of galanthamine.


propafenone may increase the QTc-prolonging activities of tamoxifen.


Quinine may increase the QTc-prolonging activities of Lenvatinib.


propafenone may increase the QTc-prolonging activities of ondansetron.


erythromycin may increase the QTc-prolonging activities of apomorphine.


erythromycin may increase the QTc-prolonging activities of paroxetine.


erythromycin may increase the QTc-prolonging activities of Ibandronic Acid.


haloperidol may increase the QTc-prolonging activities of Vorinostat.


Escitalopram may increase the QTc-prolonging activities of Ibandronic Acid.


Crizotinib may increase the QTc-prolonging activities of erythromycin.


Lenvatinib may increase the QTc-prolonging activities of lithium ion.


Telithromycin may increase the QTc-prolonging activities of diphenhydramine.


Perfluoropropane may increase the QTc-prolonging activities of maprotiline.


Perfluoropropane may increase the QTc-prolonging activities of Salmeterol.


Crizotinib may increase the QTc-prolonging activities of fluconazole.


Quinine may increase the QTc-prolonging activities of Arformoterol.


clarithromycin may increase the QTc-prolonging activities of terbutaline.


pimozide may increase the QTc-prolonging activities of Bedaquiline.


arsenic trioxide may increase the QTc-prolonging activities of Levomepromazine.


granisetron may increase the QTc-prolonging activities of propofol.


goserelin may increase the QTc-prolonging activities of Vorinostat.


quetiapine may increase the QTc-prolonging activities of Lenvatinib.


Asenapine may increase the QTc-prolonging activities of sertraline.


cisapride may increase the QTc-prolonging activities of TRIPTORELIN.


Vandetanib may increase the QTc-prolonging activities of chloroquine.


chloroquine may increase the QTc-prolonging activities of amitriptyline.


Telavancin may increase the QTc-prolonging activities of felbamate.


quetiapine may increase the QTc-prolonging activities of sulfamethoxazole.


Artemether may increase the QTc-prolonging activities of Levomepromazine.


Eribulin may increase the QTc-prolonging activities of mifepristone.


sotalol may increase the QTc-prolonging activities of flecainide.


disopyramide may increase the QTc-prolonging activities of Sunitinib.


pentamidine may increase the QTc-prolonging activities of doxepin.


goserelin may increase the QTc-prolonging activities of desipramine.


flecainide may increase the QTc-prolonging activities of haloperidol.


SAQUINAVIR may increase the QTc-prolonging activities of pentamidine.


dolasetron may increase the QTc-prolonging activities of droperidol.


Gemifloxacin may increase the QTc-prolonging activities of paroxetine.


Iloperidone may increase the QTc-prolonging activities of dolasetron.


Iloperidone may increase the QTc-prolonging activities of isoflurane.


Dofetilide may increase the QTc-prolonging activities of lithium ion.


flecainide may increase the QTc-prolonging activities of Arformoterol.


ofloxacin may increase the QTc-prolonging activities of desipramine.


disopyramide may increase the QTc-prolonging activities of flecainide.


ofloxacin may increase the QTc-prolonging activities of Gemifloxacin.


Paliperidone may increase the QTc-prolonging activities of flecainide.


Flupentixol may increase the QTc-prolonging activities of Sunitinib.


Flupentixol may increase the QTc-prolonging activities of Posaconazole.


Telithromycin may increase the QTc-prolonging activities of TRIPTORELIN.


PRIMAQUINE may increase the QTc-prolonging activities of amantadine.


PRIMAQUINE may increase the QTc-prolonging activities of metronidazole.


toremifene may increase the QTc-prolonging activities of mirtazapine.


sotalol may increase the QTc-prolonging activities of sulfamethoxazole.


toremifene may increase the QTc-prolonging activities of Treprostinil.


TETRABENAZINE may increase the QTc-prolonging activities of moxifloxacin.


Gemifloxacin may increase the QTc-prolonging activities of thiothixene.


Flupentixol may increase the QTc-prolonging activities of ceritinib.


arsenic trioxide may increase the QTc-prolonging activities of tamoxifen.


arsenic trioxide may increase the QTc-prolonging activities of galanthamine.


chloroquine may increase the QTc-prolonging activities of Rilpivirine.


pentamidine may increase the QTc-prolonging activities of nortriptyline.


pentamidine may increase the QTc-prolonging activities of amoxapine.


pimozide may increase the QTc-prolonging activities of Octreotide.


droperidol may increase the QTc-prolonging activities of nicardipine.


citalopram may increase the QTc-prolonging activities of Retigabine.


ceritinib may increase the QTc-prolonging activities of Gadobenic acid.


Pazopanib may increase the QTc-prolonging activities of ofloxacin.


fluoxetine may increase the QTc-prolonging activities of Gadobenic acid.


citalopram may increase the QTc-prolonging activities of norfloxacin.


arsenic trioxide may increase the QTc-prolonging activities of DESFLURANE.


sulfisoxazole may increase the QTc-prolonging activities of Octreotide.


Gemifloxacin may increase the QTc-prolonging activities of OLODATEROL.


arsenic trioxide may increase the QTc-prolonging activities of Voriconazole.


Gemifloxacin may increase the QTc-prolonging activities of Vilanterol.


Gemifloxacin may increase the QTc-prolonging activities of Ivabradine.


Telithromycin may increase the QTc-prolonging activities of haloperidol.


cisapride may increase the QTc-prolonging activities of Lapatinib.


Nilotinib may increase the QTc-prolonging activities of ofloxacin.


ceritinib may increase the QTc-prolonging activities of foscarnet.


Iloperidone may increase the QTc-prolonging activities of Atomoxetine.


Lumefantrine may increase the QTc-prolonging activities of amitriptyline.


Iloperidone may increase the QTc-prolonging activities of venlafaxine.


Telavancin may increase the QTc-prolonging activities of trimethoprim.


Iloperidone may increase the QTc-prolonging activities of Gemifloxacin.


toremifene may increase the QTc-prolonging activities of lithium ion.


Iloperidone may increase the QTc-prolonging activities of desipramine.


Gemifloxacin may increase the QTc-prolonging activities of Vardenafil.


erythromycin may increase the QTc-prolonging activities of goserelin.


Paliperidone may increase the QTc-prolonging activities of paroxetine.


Paliperidone may increase the QTc-prolonging activities of apomorphine.


Asenapine may increase the QTc-prolonging activities of histrelin.


Paliperidone may increase the QTc-prolonging activities of Ibandronic Acid.


LEVOFLOXACIN may increase the QTc-prolonging activities of metoclopramide.


thioridazine may increase the QTc-prolonging activities of apomorphine.


quinidine may increase the QTc-prolonging activities of sulfamethoxazole.


thioridazine may increase the QTc-prolonging activities of Ibandronic Acid.


Telithromycin may increase the QTc-prolonging activities of sulfisoxazole.


Gemifloxacin may increase the QTc-prolonging activities of apomorphine.


Gemifloxacin may increase the QTc-prolonging activities of Ibandronic Acid.


moxifloxacin may increase the QTc-prolonging activities of TRIPTORELIN.


cisapride may increase the QTc-prolonging activities of thiothixene.


pimozide may increase the QTc-prolonging activities of propofol.


Flupentixol may increase the QTc-prolonging activities of propofol.


Paliperidone may increase the QTc-prolonging activities of tamoxifen.


arsenic trioxide may increase the QTc-prolonging activities of propafenone.


Ziprasidone may increase the QTc-prolonging activities of protriptyline.


Ziprasidone may increase the QTc-prolonging activities of alfuzosin.


promazine may increase the QTc-prolonging activities of sertraline.


quinidine may increase the QTc-prolonging activities of OLODATEROL.


quinidine may increase the QTc-prolonging activities of Vilanterol.


Atracurium besylate may increase the neuromuscular blocking activities of demeclocycline.


Atracurium besylate may increase the neuromuscular blocking activities of diltiazem.


Atracurium besylate may increase the neuromuscular blocking activities of lincomycin.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of demeclocycline.


succinylcholine may increase the neuromuscular blocking activities of quinidine.


Mivacurium may increase the neuromuscular blocking activities of xylometazoline.


succinylcholine may increase the neuromuscular blocking activities of Colistimethate.


Mivacurium may increase the neuromuscular blocking activities of nitrous oxide.


Mivacurium may increase the neuromuscular blocking activities of lincomycin.


pancuronium may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Mivacurium may increase the neuromuscular blocking activities of DESFLURANE.


Mivacurium may increase the neuromuscular blocking activities of demeclocycline.


Atracurium besylate may increase the neuromuscular blocking activities of Quinine.


Epirubicin may increase the neuromuscular blocking activities of capreomycin.


decamethonium may increase the neuromuscular blocking activities of doxycycline.


Atracurium besylate may increase the neuromuscular blocking activities of chlortetracycline.


mecamylamine may increase the neuromuscular blocking activities of netilmicin.


Atracurium besylate may increase the neuromuscular blocking activities of Pinaverium.


Cisatracurium may increase the neuromuscular blocking activities of VANCOMYCIN.


decamethonium may increase the neuromuscular blocking activities of capreomycin.


Atracurium besylate may increase the neuromuscular blocking activities of VERAPAMIL.


mecamylamine may increase the neuromuscular blocking activities of paromomycin.


tubocurarine may increase the neuromuscular blocking activities of minocycline.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of lincomycin.


Cisatracurium may increase the neuromuscular blocking activities of chlortetracycline.


mecamylamine may increase the neuromuscular blocking activities of clindamycin.


PYRANTEL may increase the neuromuscular blocking activities of cyclosporin A.


Rocuronium may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


streptomycin may increase the neuromuscular blocking activities of capreomycin.


metrizamide may increase the neuromuscular blocking activities of capreomycin.


Colistimethate may increase the neuromuscular blocking activities of polymyxin b.


decamethonium may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


PYRANTEL may increase the neuromuscular blocking activities of Quinine.


PIPECURONIUM may increase the neuromuscular blocking activities of quinidine.


tubocurarine may increase the neuromuscular blocking activities of chlortetracycline.


PIPECURONIUM may increase the neuromuscular blocking activities of capreomycin.


kanamycin may increase the neuromuscular blocking activities of capreomycin.


PIPECURONIUM may increase the neuromuscular blocking activities of doxycycline.


Rocuronium may increase the neuromuscular blocking activities of cyclosporin A.


Cisatracurium may increase the neuromuscular blocking activities of PROCAINAMIDE.


succinylcholine may increase the neuromuscular blocking activities of Magnesium salicylate.


PIPECURONIUM may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Doxacurium may increase the neuromuscular blocking activities of minocycline.


Doxacurium may increase the neuromuscular blocking activities of Magnesium salicylate.


Vecuronium may increase the neuromuscular blocking activities of polymyxin b.


METOCURINE may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Cisatracurium may increase the neuromuscular blocking activities of capreomycin.


mecamylamine may increase the neuromuscular blocking activities of plicamycin.


Cisatracurium may increase the neuromuscular blocking activities of doxycycline.


Mivacurium may increase the neuromuscular blocking activities of barnidipine.


Rocuronium may increase the neuromuscular blocking activities of lithium ion.


succinylcholine may increase the neuromuscular blocking activities of minocycline.


Doxacurium may increase the neuromuscular blocking activities of chlortetracycline.


decamethonium may increase the neuromuscular blocking activities of PROCAINAMIDE.


Atracurium besylate may increase the neuromuscular blocking activities of cyclosporin A.


Atracurium besylate may increase the neuromuscular blocking activities of nimodipine.


Mivacurium may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


Doxacurium may increase the neuromuscular blocking activities of Quinine.


tubocurarine may increase the neuromuscular blocking activities of Magnesium salicylate.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of capreomycin.


mecamylamine may increase the neuromuscular blocking activities of Spectinomycin.


METOCURINE may increase the neuromuscular blocking activities of polymyxin b.


Atracurium besylate may increase the neuromuscular blocking activities of Pregabalin.


tubocurarine may increase the neuromuscular blocking activities of clindamycin.


Atracurium besylate may increase the neuromuscular blocking activities of nicardipine.


PYRANTEL may increase the neuromuscular blocking activities of VANCOMYCIN.


Atracurium besylate may increase the neuromuscular blocking activities of polymyxin b.


mecamylamine may increase the neuromuscular blocking activities of capreomycin.


PYRANTEL may increase the neuromuscular blocking activities of chlortetracycline.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of PROCAINAMIDE.


succinylcholine may increase the neuromuscular blocking activities of doxycycline.


METOCURINE may increase the neuromuscular blocking activities of cyclosporin A.


IDARUBICIN may increase the neuromuscular blocking activities of capreomycin.


Cisatracurium may increase the neuromuscular blocking activities of polymyxin b.


METOCURINE may increase the neuromuscular blocking activities of lincomycin.


decamethonium may increase the neuromuscular blocking activities of demeclocycline.


succinylcholine may increase the neuromuscular blocking activities of demeclocycline.


Cisatracurium may increase the neuromuscular blocking activities of lincomycin.


mecamylamine may increase the neuromuscular blocking activities of lincomycin.


Mivacurium may increase the neuromuscular blocking activities of isradipine.


Mivacurium may increase the neuromuscular blocking activities of TRICHLOROETHYLENE.


METOCURINE may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


decamethonium may increase the neuromuscular blocking activities of lincomycin.


succinylcholine may increase the neuromuscular blocking activities of lincomycin.


mecamylamine may increase the neuromuscular blocking activities of Valrubicin.


PYRANTEL may increase the neuromuscular blocking activities of PROCAINAMIDE.


Cisatracurium may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


PIPECURONIUM may increase the neuromuscular blocking activities of PROCAINAMIDE.


pancuronium may increase the neuromuscular blocking activities of capreomycin.


mecamylamine may increase the neuromuscular blocking activities of Epirubicin.


Atracurium besylate may increase the neuromuscular blocking activities of gabapentin.


decamethonium may increase the neuromuscular blocking activities of Quinine.


Vecuronium may increase the neuromuscular blocking activities of quinidine.


pancuronium may increase the neuromuscular blocking activities of cyclosporin A.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of lithium ion.


Vecuronium may increase the neuromuscular blocking activities of VANCOMYCIN.


Atracurium besylate may increase the neuromuscular blocking activities of bepridil.


tubocurarine may increase the neuromuscular blocking activities of VANCOMYCIN.


Atracurium besylate may increase the neuromuscular blocking activities of nifedipine.


mecamylamine may increase the neuromuscular blocking activities of demeclocycline.


Doxacurium may increase the neuromuscular blocking activities of PROCAINAMIDE.


Atracurium besylate may increase the neuromuscular blocking activities of Colistimethate.


succinylcholine may increase the neuromuscular blocking activities of chlortetracycline.


Atracurium besylate may increase the neuromuscular blocking activities of nitrendipine.


Vecuronium may increase the neuromuscular blocking activities of chlortetracycline.


Mivacurium may increase the neuromuscular blocking activities of Amrinone.


Atracurium besylate may increase the neuromuscular blocking activities of quinidine.


Mivacurium may increase the neuromuscular blocking activities of lithium ion.


Mivacurium may increase the neuromuscular blocking activities of nitrendipine.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of Quinine.


plicamycin may increase the neuromuscular blocking activities of capreomycin.


mecamylamine may increase the neuromuscular blocking activities of tobramycin.


Doxacurium may increase the neuromuscular blocking activities of clindamycin.


Vecuronium may increase the neuromuscular blocking activities of Quinine.


Vecuronium may increase the neuromuscular blocking activities of Colistimethate.


Atracurium besylate may increase the neuromuscular blocking activities of isradipine.


PYRANTEL may increase the neuromuscular blocking activities of doxycycline.


streptozocin may increase the neuromuscular blocking activities of capreomycin.


Cisatracurium may increase the neuromuscular blocking activities of clindamycin.


METOCURINE may increase the neuromuscular blocking activities of capreomycin.


tobramycin may increase the neuromuscular blocking activities of capreomycin.


Rocuronium may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Atracurium besylate may increase the neuromuscular blocking activities of isoflurane.


PYRANTEL may increase the neuromuscular blocking activities of polymyxin b.


succinylcholine may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


Mivacurium may increase the neuromuscular blocking activities of Pregabalin.


METOCURINE may increase the neuromuscular blocking activities of PROCAINAMIDE.


Doxacurium may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


decamethonium may increase the neuromuscular blocking activities of cyclosporin A.


pancuronium may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


PIPECURONIUM may increase the neuromuscular blocking activities of polymyxin b.


succinylcholine may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Cisatracurium may increase the neuromuscular blocking activities of demeclocycline.


pancuronium may increase the neuromuscular blocking activities of Colistimethate.


Atracurium besylate may increase the neuromuscular blocking activities of TRICHLOROETHYLENE.


PYRANTEL may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Cisatracurium may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Atracurium besylate may increase the neuromuscular blocking activities of cilnidipine.


Atracurium besylate may increase the neuromuscular blocking activities of Benidipine.


Atracurium besylate may increase the neuromuscular blocking activities of Azelnidipine.


Atracurium besylate may increase the neuromuscular blocking activities of Lacidipine.


Atracurium besylate may increase the neuromuscular blocking activities of Efonidipine.


Atracurium besylate may increase the neuromuscular blocking activities of xylometazoline.


PIPECURONIUM may increase the neuromuscular blocking activities of chlortetracycline.


Atracurium besylate may increase the neuromuscular blocking activities of manidipine.


Atracurium besylate may increase the neuromuscular blocking activities of nitrous oxide.


Atracurium besylate may increase the neuromuscular blocking activities of nisoldipine.


Cisatracurium may increase the neuromuscular blocking activities of cyclosporin A.


Rocuronium may increase the neuromuscular blocking activities of clindamycin.


Amrubicin may increase the neuromuscular blocking activities of capreomycin.


decamethonium may increase the neuromuscular blocking activities of polymyxin b.


succinylcholine may increase the neuromuscular blocking activities of Phenelzine.


succinylcholine may increase the neuromuscular blocking activities of polymyxin b.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of polymyxin b.


tubocurarine may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


Atracurium besylate may increase the neuromuscular blocking activities of minocycline.


METOCURINE may increase the neuromuscular blocking activities of chlortetracycline.


mecamylamine may increase the neuromuscular blocking activities of Amrubicin.


pancuronium may increase the neuromuscular blocking activities of lincomycin.


Rocuronium may increase the neuromuscular blocking activities of polymyxin b.


mecamylamine may increase the neuromuscular blocking activities of chlortetracycline.


pancuronium may increase the neuromuscular blocking activities of demeclocycline.


Mivacurium may increase the neuromuscular blocking activities of Lacidipine.


Mivacurium may increase the neuromuscular blocking activities of Efonidipine.


Mivacurium may increase the neuromuscular blocking activities of cilnidipine.


Mivacurium may increase the neuromuscular blocking activities of minocycline.


Mivacurium may increase the neuromuscular blocking activities of Azelnidipine.


Mivacurium may increase the neuromuscular blocking activities of Benidipine.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of doxycycline.


Mivacurium may increase the neuromuscular blocking activities of manidipine.


Vecuronium may increase the neuromuscular blocking activities of minocycline.


Mivacurium may increase the neuromuscular blocking activities of spironolactone.


Atracurium besylate may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


netilmicin may increase the neuromuscular blocking activities of capreomycin.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of cyclosporin A.


Mivacurium may increase the neuromuscular blocking activities of nimodipine.


Cisatracurium may increase the neuromuscular blocking activities of capreomycin.


METOCURINE may increase the neuromuscular blocking activities of Quinine.


PYRANTEL may increase the neuromuscular blocking activities of clindamycin.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of VANCOMYCIN.


mecamylamine may increase the neuromuscular blocking activities of minocycline.


pancuronium may increase the neuromuscular blocking activities of quinidine.


Mivacurium may increase the neuromuscular blocking activities of polymyxin b.


amikacin may increase the neuromuscular blocking activities of capreomycin.


Rocuronium may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


Atracurium besylate may increase the neuromuscular blocking activities of halothane.


Mivacurium may increase the neuromuscular blocking activities of nimesulide.


pancuronium may increase the neuromuscular blocking activities of clindamycin.


Mivacurium may increase the neuromuscular blocking activities of chlortetracycline.


Mivacurium may increase the neuromuscular blocking activities of Pinaverium.


Cisatracurium may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


decamethonium may increase the neuromuscular blocking activities of Colistimethate.


Doxacurium may increase the neuromuscular blocking activities of demeclocycline.


pancuronium may increase the neuromuscular blocking activities of minocycline.


decamethonium may increase the neuromuscular blocking activities of quinidine.


mecamylamine may increase the neuromuscular blocking activities of streptomycin.


pancuronium may increase the neuromuscular blocking activities of Magnesium salicylate.


Vecuronium may increase the neuromuscular blocking activities of demeclocycline.


Rocuronium may increase the neuromuscular blocking activities of Magnesium salicylate.


Rocuronium may increase the neuromuscular blocking activities of minocycline.


PYRANTEL may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Atracurium besylate may increase the neuromuscular blocking activities of Lercanidipine.


Mivacurium may increase the neuromuscular blocking activities of diltiazem.


PIPECURONIUM may increase the neuromuscular blocking activities of lincomycin.


Rocuronium may increase the neuromuscular blocking activities of lincomycin.


Valrubicin may increase the neuromuscular blocking activities of capreomycin.


Vecuronium may increase the neuromuscular blocking activities of lincomycin.


pancuronium may increase the neuromuscular blocking activities of chlortetracycline.


tubocurarine may increase the neuromuscular blocking activities of lincomycin.


Mivacurium may increase the neuromuscular blocking activities of Colistimethate.


PIPECURONIUM may increase the neuromuscular blocking activities of demeclocycline.


daunorubicin may increase the neuromuscular blocking activities of capreomycin.


pancuronium may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


Cisatracurium may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


tubocurarine may increase the neuromuscular blocking activities of doxycycline.


Rocuronium may increase the neuromuscular blocking activities of quinidine.


Mivacurium may increase the neuromuscular blocking activities of Quinine.


Vecuronium may increase the neuromuscular blocking activities of clindamycin.


tubocurarine may increase the neuromuscular blocking activities of Quinine.


tubocurarine may increase the neuromuscular blocking activities of capreomycin.


Rocuronium may increase the neuromuscular blocking activities of capreomycin.


Atracurium besylate may increase the neuromuscular blocking activities of eperisone.


Doxacurium may increase the neuromuscular blocking activities of lithium ion.


Atracurium besylate may increase the neuromuscular blocking activities of sevoflurane.


PYRANTEL may increase the neuromuscular blocking activities of capreomycin.


Cisatracurium may increase the neuromuscular blocking activities of Colistimethate.


Cisatracurium may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


decamethonium may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


METOCURINE may increase the neuromuscular blocking activities of doxycycline.


METOCURINE may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Mivacurium may increase the neuromuscular blocking activities of gabapentin.


succinylcholine may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Cisatracurium may increase the neuromuscular blocking activities of quinidine.


Mivacurium may increase the neuromuscular blocking activities of methoxyflurane.


Cisatracurium may increase the neuromuscular blocking activities of demeclocycline.


METOCURINE may increase the neuromuscular blocking activities of lithium ion.


pancuronium may increase the neuromuscular blocking activities of polymyxin b.


Mivacurium may increase the neuromuscular blocking activities of felodipine.


Rocuronium may increase the neuromuscular blocking activities of demeclocycline.


Atracurium besylate may increase the neuromuscular blocking activities of clindamycin.


mecamylamine may increase the neuromuscular blocking activities of daunorubicin.


Mivacurium may increase the neuromuscular blocking activities of quinidine.


Mivacurium may increase the neuromuscular blocking activities of VANCOMYCIN.


Atracurium besylate may increase the neuromuscular blocking activities of Amrinone.


Vecuronium may increase the neuromuscular blocking activities of doxycycline.


mecamylamine may increase the neuromuscular blocking activities of polymyxin b.


METOCURINE may increase the neuromuscular blocking activities of VANCOMYCIN.


Cisatracurium may increase the neuromuscular blocking activities of VANCOMYCIN.


Doxacurium may increase the neuromuscular blocking activities of lincomycin.


decamethonium may increase the neuromuscular blocking activities of minocycline.


pancuronium may increase the neuromuscular blocking activities of lithium ion.


Cisatracurium may increase the neuromuscular blocking activities of minocycline.


Mivacurium may increase the neuromuscular blocking activities of sevoflurane.


Vecuronium may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


succinylcholine may increase the neuromuscular blocking activities of capreomycin.


Vecuronium may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Mivacurium may increase the neuromuscular blocking activities of nilvadipine.


Rocuronium may increase the neuromuscular blocking activities of Colistimethate.


tubocurarine may increase the neuromuscular blocking activities of lithium ion.


Mivacurium may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Atracurium besylate may increase the neuromuscular blocking activities of cinnarizine.


Mivacurium may increase the neuromuscular blocking activities of enflurane.


PIPECURONIUM may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


Rocuronium may increase the neuromuscular blocking activities of Quinine.


tubocurarine may increase the neuromuscular blocking activities of cyclosporin A.


Vecuronium may increase the neuromuscular blocking activities of cyclosporin A.


Mivacurium may increase the neuromuscular blocking activities of halothane.


Cisatracurium may increase the neuromuscular blocking activities of cyclosporin A.


PIPECURONIUM may increase the neuromuscular blocking activities of cyclosporin A.


ribostamycin may increase the neuromuscular blocking activities of capreomycin.


tubocurarine may increase the neuromuscular blocking activities of PROCAINAMIDE.


Mivacurium may increase the neuromuscular blocking activities of cyclosporin A.


decamethonium may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Atracurium besylate may increase the neuromuscular blocking activities of barnidipine.


Mivacurium may increase the neuromuscular blocking activities of capreomycin.


Cisatracurium may increase the neuromuscular blocking activities of clindamycin.


mecamylamine may increase the neuromuscular blocking activities of ribostamycin.


Mivacurium may increase the neuromuscular blocking activities of doxycycline.


Cisatracurium may increase the neuromuscular blocking activities of lincomycin.


Atracurium besylate may increase the neuromuscular blocking activities of methoxyflurane.


mecamylamine may increase the neuromuscular blocking activities of metrizamide.


mecamylamine may increase the neuromuscular blocking activities of Colistimethate.


METOCURINE may increase the neuromuscular blocking activities of clindamycin.


tubocurarine may increase the neuromuscular blocking activities of polymyxin b.


PYRANTEL may increase the neuromuscular blocking activities of Colistimethate.


Cisatracurium may increase the neuromuscular blocking activities of minocycline.


Cisatracurium may increase the neuromuscular blocking activities of Magnesium salicylate.


PIPECURONIUM may increase the neuromuscular blocking activities of clindamycin.


METOCURINE may increase the neuromuscular blocking activities of Magnesium salicylate.


Atracurium besylate may increase the neuromuscular blocking activities of DESFLURANE.


Mivacurium may increase the neuromuscular blocking activities of Risedronic acid.


Atracurium besylate may increase the neuromuscular blocking activities of Magnesium salicylate.


polymyxin b may increase the neuromuscular blocking activities of capreomycin.


PYRANTEL may increase the neuromuscular blocking activities of quinidine.


Cisatracurium may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


PYRANTEL may increase the neuromuscular blocking activities of demeclocycline.


mecamylamine may increase the neuromuscular blocking activities of gentamicin.


succinylcholine may increase the neuromuscular blocking activities of PROCAINAMIDE.


Cisatracurium may increase the neuromuscular blocking activities of polymyxin b.


Cisatracurium may increase the neuromuscular blocking activities of Colistimethate.


Mivacurium may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Mivacurium may increase the neuromuscular blocking activities of PERHEXILINE.


Mivacurium may increase the neuromuscular blocking activities of Clevidipine.


PIPECURONIUM may increase the neuromuscular blocking activities of lithium ion.


Atracurium besylate may increase the neuromuscular blocking activities of nilvadipine.


doxorubicin may increase the neuromuscular blocking activities of capreomycin.


Arbekacin may increase the neuromuscular blocking activities of capreomycin.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of minocycline.


Mivacurium may increase the neuromuscular blocking activities of clindamycin.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of Colistimethate.


decamethonium may increase the neuromuscular blocking activities of clindamycin.


Vecuronium may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Colistimethate may increase the neuromuscular blocking activities of capreomycin.


Rocuronium may increase the neuromuscular blocking activities of chlortetracycline.


Atracurium besylate may increase the neuromuscular blocking activities of VANCOMYCIN.


Rocuronium may increase the neuromuscular blocking activities of doxycycline.


METOCURINE may increase the neuromuscular blocking activities of minocycline.


PYRANTEL may increase the neuromuscular blocking activities of lincomycin.


succinylcholine may increase the neuromuscular blocking activities of lithium ion.


succinylcholine may increase the neuromuscular blocking activities of clindamycin.


Atracurium besylate may increase the neuromuscular blocking activities of lithium ion.


gentamicin may increase the neuromuscular blocking activities of capreomycin.


Atracurium besylate may increase the neuromuscular blocking activities of felodipine.


PYRANTEL may increase the neuromuscular blocking activities of minocycline.


mecamylamine may increase the neuromuscular blocking activities of streptozocin.


PYRANTEL may increase the neuromuscular blocking activities of Magnesium salicylate.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


pancuronium may increase the neuromuscular blocking activities of Quinine.


decamethonium may increase the neuromuscular blocking activities of chlortetracycline.


PYRANTEL may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


Mivacurium may increase the neuromuscular blocking activities of isoflurane.


paromomycin may increase the neuromuscular blocking activities of capreomycin.


Atracurium besylate may increase the neuromuscular blocking activities of PERHEXILINE.


Cisatracurium may increase the neuromuscular blocking activities of Quinine.


tubocurarine may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Atracurium besylate may increase the neuromuscular blocking activities of Risedronic acid.


Cisatracurium may increase the neuromuscular blocking activities of Magnesium salicylate.


Mivacurium may increase the neuromuscular blocking activities of eperisone.


Spectinomycin may increase the neuromuscular blocking activities of capreomycin.


Mivacurium may increase the neuromuscular blocking activities of PROCAINAMIDE.


PIPECURONIUM may increase the neuromuscular blocking activities of Magnesium salicylate.


Cisatracurium may increase the neuromuscular blocking activities of lithium ion.


Mivacurium may increase the neuromuscular blocking activities of Lercanidipine.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of chlortetracycline.


PIPECURONIUM may increase the neuromuscular blocking activities of minocycline.


Doxacurium may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Atracurium besylate may increase the neuromuscular blocking activities of capreomycin.


Doxacurium may increase the neuromuscular blocking activities of doxycycline.


Mivacurium may increase the neuromuscular blocking activities of Magnesium salicylate.


Doxacurium may increase the neuromuscular blocking activities of capreomycin.


Doxacurium may increase the neuromuscular blocking activities of cyclosporin A.


pancuronium may increase the neuromuscular blocking activities of VANCOMYCIN.


decamethonium may increase the neuromuscular blocking activities of Magnesium salicylate.


Doxacurium may increase the neuromuscular blocking activities of quinidine.


Mivacurium may increase the neuromuscular blocking activities of bepridil.


Vecuronium may increase the neuromuscular blocking activities of capreomycin.


Mivacurium may increase the neuromuscular blocking activities of nicardipine.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of Magnesium salicylate.


Vecuronium may increase the neuromuscular blocking activities of piperacillin.


tubocurarine may increase the neuromuscular blocking activities of quinidine.


Atracurium besylate may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Atracurium besylate may increase the neuromuscular blocking activities of enflurane.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of quinidine.


pancuronium may increase the neuromuscular blocking activities of doxycycline.


Atracurium besylate may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


Rocuronium may increase the neuromuscular blocking activities of VANCOMYCIN.


METOCURINE may increase the neuromuscular blocking activities of Colistimethate.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of MAGNESIUM SULFATE.


Cisatracurium may increase the neuromuscular blocking activities of chlortetracycline.


pancuronium may increase the neuromuscular blocking activities of PROCAINAMIDE.


Doxacurium may increase the neuromuscular blocking activities of polymyxin b.


Atracurium besylate may increase the neuromuscular blocking activities of doxycycline.


PIPECURONIUM may increase the neuromuscular blocking activities of Quinine.


Atracurium besylate may increase the neuromuscular blocking activities of tolfenamic acid.


tubocurarine may increase the neuromuscular blocking activities of demeclocycline.


succinylcholine may increase the neuromuscular blocking activities of cyclosporin A.


Rocuronium may increase the neuromuscular blocking activities of PROCAINAMIDE.


Atracurium besylate may increase the neuromuscular blocking activities of spironolactone.


Atracurium besylate may increase the neuromuscular blocking activities of flunarizine.


mecamylamine may increase the neuromuscular blocking activities of doxorubicin.


tubocurarine may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


tubocurarine may increase the neuromuscular blocking activities of Colistimethate.


Atracurium besylate may increase the neuromuscular blocking activities of Clevidipine.


mecamylamine may increase the neuromuscular blocking activities of doxycycline.


METOCURINE may increase the neuromuscular blocking activities of quinidine.


METOCURINE may increase the neuromuscular blocking activities of demeclocycline.


mecamylamine may increase the neuromuscular blocking activities of amikacin.


PIPECURONIUM may increase the neuromuscular blocking activities of VANCOMYCIN.


Cisatracurium may increase the neuromuscular blocking activities of lithium ion.


Mivacurium may increase the neuromuscular blocking activities of flunarizine.


Cisatracurium may increase the neuromuscular blocking activities of Quinine.


decamethonium may increase the neuromuscular blocking activities of VANCOMYCIN.


mecamylamine may increase the neuromuscular blocking activities of Arbekacin.


Mivacurium may increase the neuromuscular blocking activities of cinnarizine.


succinylcholine may increase the neuromuscular blocking activities of VANCOMYCIN.


Vecuronium may increase the neuromuscular blocking activities of Magnesium salicylate.


Vecuronium may increase the neuromuscular blocking activities of PROCAINAMIDE.


PIPECURONIUM may increase the neuromuscular blocking activities of Colistimethate.


Atracurium besylate may increase the neuromuscular blocking activities of nimesulide.


PYRANTEL may increase the neuromuscular blocking activities of lithium ion.


Doxacurium may increase the neuromuscular blocking activities of MAGNESIUM OXIDE.


Vecuronium may increase the neuromuscular blocking activities of dantrolene.


Mivacurium may increase the neuromuscular blocking activities of nisoldipine.


Vecuronium may increase the neuromuscular blocking activities of lithium ion.


mecamylamine may increase the neuromuscular blocking activities of kanamycin.


Doxacurium may increase the neuromuscular blocking activities of Colistimethate.


decamethonium may increase the neuromuscular blocking activities of lithium ion.


mecamylamine may increase the neuromuscular blocking activities of IDARUBICIN.


PIPECURONIUM may increase the neuromuscular blocking activities of MAGNESIUM HYDROXIDE.


Mivacurium may increase the neuromuscular blocking activities of nifedipine.


GALLAMINE TRIETHIODIDE may increase the neuromuscular blocking activities of clindamycin.


Mivacurium may increase the neuromuscular blocking activities of VERAPAMIL.


succinylcholine may increase the neuromuscular blocking activities of Quinine.


Atracurium besylate may increase the neuromuscular blocking activities of PROCAINAMIDE.


Doxacurium may increase the neuromuscular blocking activities of VANCOMYCIN.


Mivacurium may increase the neuromuscular blocking activities of tolfenamic acid.


Fluticasone furoate may increase the adverse neuromuscular activities of Atracurium besylate.


Dehydroepiandrosterone may increase the adverse neuromuscular activities of Mivacurium.


diflorasone may increase the adverse neuromuscular activities of Mivacurium.


flumethasone may increase the adverse neuromuscular activities of Atracurium besylate.


desoximetasone may increase the adverse neuromuscular activities of Atracurium besylate.


Mometasone may increase the adverse neuromuscular activities of Mivacurium.


CLOBETASOL PROPIONATE may increase the adverse neuromuscular activities of Atracurium besylate.


estrone may increase the adverse neuromuscular activities of Mivacurium.


difluprednate may increase the adverse neuromuscular activities of Atracurium besylate.


prednisone may increase the adverse neuromuscular activities of Mivacurium.


Fluprednidene may increase the adverse neuromuscular activities of Mivacurium.


diflorasone may increase the adverse neuromuscular activities of Atracurium besylate.


BECLOMETHASONE DIPROPIONATE may increase the adverse neuromuscular activities of Atracurium besylate.


dexamethasone may increase the adverse neuromuscular activities of Mivacurium.


Tixocortol may increase the adverse neuromuscular activities of Mivacurium.


FLUTICASONE PROPIONATE may increase the adverse neuromuscular activities of Atracurium besylate.


fluocinonide may increase the adverse neuromuscular activities of Mivacurium.


Ciclesonide may increase the adverse neuromuscular activities of Atracurium besylate.


CORTISONE ACETATE may increase the adverse neuromuscular activities of Atracurium besylate.


FLUTICASONE PROPIONATE may increase the adverse neuromuscular activities of Mivacurium.


alclometasone may increase the adverse neuromuscular activities of Atracurium besylate.


fludrocortisone may increase the adverse neuromuscular activities of Mivacurium.


flunisolide may increase the adverse neuromuscular activities of Mivacurium.


difluprednate may increase the adverse neuromuscular activities of Mivacurium.


triamcinolone may increase the adverse neuromuscular activities of Atracurium besylate.


FLUOCINOLONE ACETONIDE may increase the adverse neuromuscular activities of Atracurium besylate.


paramethasone may increase the adverse neuromuscular activities of Mivacurium.


PREDNICARBATE may increase the adverse neuromuscular activities of Mivacurium.


Tixocortol may increase the adverse neuromuscular activities of Atracurium besylate.


RIMEXOLONE may increase the adverse neuromuscular activities of Mivacurium.


Fluprednidene may increase the adverse neuromuscular activities of Atracurium besylate.


betamethasone may increase the adverse neuromuscular activities of Mivacurium.


DEFLAZACORT may increase the adverse neuromuscular activities of Mivacurium.


alclometasone may increase the adverse neuromuscular activities of Mivacurium.


DESONIDE may increase the adverse neuromuscular activities of Atracurium besylate.


CORTISONE ACETATE may increase the adverse neuromuscular activities of Mivacurium.


amcinonide may increase the adverse neuromuscular activities of Atracurium besylate.


triamcinolone may increase the adverse neuromuscular activities of Mivacurium.


Estrone sulfate may increase the adverse neuromuscular activities of Atracurium besylate.


methylprednisolone may increase the adverse neuromuscular activities of Mivacurium.


equilin may increase the adverse neuromuscular activities of Atracurium besylate.


fludrocortisone may increase the adverse neuromuscular activities of Atracurium besylate.


Halobetasol may increase the adverse neuromuscular activities of Atracurium besylate.


flunisolide may increase the adverse neuromuscular activities of Atracurium besylate.


loteprednol may increase the adverse neuromuscular activities of Atracurium besylate.


halcinonide may increase the adverse neuromuscular activities of Mivacurium.


formestane may increase the adverse neuromuscular activities of Atracurium besylate.


FLUOCORTOLONE may increase the adverse neuromuscular activities of Mivacurium.


estrone may increase the adverse neuromuscular activities of Atracurium besylate.


flurandrenolide may increase the adverse neuromuscular activities of Mivacurium.


budesonide may increase the adverse neuromuscular activities of Atracurium besylate.


flurandrenolide may increase the adverse neuromuscular activities of Atracurium besylate.


methylprednisolone may increase the adverse neuromuscular activities of Atracurium besylate.


RIMEXOLONE may increase the adverse neuromuscular activities of Atracurium besylate.


amcinonide may increase the adverse neuromuscular activities of Mivacurium.


prednisone may increase the adverse neuromuscular activities of Atracurium besylate.


CLOBETASOL PROPIONATE may increase the adverse neuromuscular activities of Mivacurium.


medrysone may increase the adverse neuromuscular activities of Atracurium besylate.


paramethasone may increase the adverse neuromuscular activities of Atracurium besylate.


BECLOMETHASONE DIPROPIONATE may increase the adverse neuromuscular activities of Mivacurium.


Ciclesonide may increase the adverse neuromuscular activities of Mivacurium.


fluocinonide may increase the adverse neuromuscular activities of Atracurium besylate.


loteprednol may increase the adverse neuromuscular activities of Mivacurium.


Estrone sulfate may increase the adverse neuromuscular activities of Mivacurium.


DEFLAZACORT may increase the adverse neuromuscular activities of Atracurium besylate.


FLUOCINOLONE ACETONIDE may increase the adverse neuromuscular activities of Mivacurium.


CLOCORTOLONE may increase the adverse neuromuscular activities of Atracurium besylate.


hydrocortisone may increase the adverse neuromuscular activities of Mivacurium.


PREDNICARBATE may increase the adverse neuromuscular activities of Atracurium besylate.


Fluticasone furoate may increase the adverse neuromuscular activities of Mivacurium.


DESONIDE may increase the adverse neuromuscular activities of Mivacurium.


betamethasone may increase the adverse neuromuscular activities of Atracurium besylate.


Dehydroepiandrosterone may increase the adverse neuromuscular activities of Atracurium besylate.


medrysone may increase the adverse neuromuscular activities of Mivacurium.


FLUOCORTOLONE may increase the adverse neuromuscular activities of Atracurium besylate.


flumethasone may increase the adverse neuromuscular activities of Mivacurium.


formestane may increase the adverse neuromuscular activities of Mivacurium.


Clobetasone may increase the adverse neuromuscular activities of Atracurium besylate.


CLOCORTOLONE may increase the adverse neuromuscular activities of Mivacurium.


desoximetasone may increase the adverse neuromuscular activities of Mivacurium.


budesonide may increase the adverse neuromuscular activities of Mivacurium.


hydrocortisone may increase the adverse neuromuscular activities of Atracurium besylate.


dexamethasone may increase the adverse neuromuscular activities of Atracurium besylate.


halcinonide may increase the adverse neuromuscular activities of Atracurium besylate.


equilin may increase the adverse neuromuscular activities of Mivacurium.


Mometasone may increase the adverse neuromuscular activities of Atracurium besylate.


Halobetasol may increase the adverse neuromuscular activities of Mivacurium.


Clobetasone may increase the adverse neuromuscular activities of Mivacurium.


Amfepramone may increase the stimulatory activities of nortriptyline.


Amfepramone may increase the stimulatory activities of amoxapine.


hydroxyamphetamine may increase the stimulatory activities of desipramine.


Lisdexamfetamine may increase the stimulatory activities of cyclobenzaprine.


hydroxyamphetamine may increase the stimulatory activities of Tianeptine.


Amfepramone may increase the stimulatory activities of imipramine.


Amfepramone may increase the stimulatory activities of clomipramine.


hydroxyamphetamine may increase the stimulatory activities of amoxapine.


hydroxyamphetamine may increase the stimulatory activities of nortriptyline.


dextroamphetamine may increase the stimulatory activities of amoxapine.


dextroamphetamine may increase the stimulatory activities of nortriptyline.


AMPHETAMINE may increase the stimulatory activities of amitriptyline.


dextroamphetamine may increase the stimulatory activities of trimipramine.


Lisdexamfetamine may increase the stimulatory activities of imipramine.


Lisdexamfetamine may increase the stimulatory activities of amitriptyline.


hydroxyamphetamine may increase the stimulatory activities of amitriptyline.


Amfepramone may increase the stimulatory activities of cyclobenzaprine.


Amfepramone may increase the stimulatory activities of Tianeptine.


Amfepramone may increase the stimulatory activities of trimipramine.


hydroxyamphetamine may increase the stimulatory activities of protriptyline.


hydroxyamphetamine may increase the stimulatory activities of trimipramine.


hydroxyamphetamine may increase the stimulatory activities of Dothiepin.


Lisdexamfetamine may increase the stimulatory activities of protriptyline.


Amfepramone may increase the stimulatory activities of amitriptyline.


dextroamphetamine may increase the stimulatory activities of protriptyline.


Lisdexamfetamine may increase the stimulatory activities of nortriptyline.


Lisdexamfetamine may increase the stimulatory activities of amoxapine.


AMPHETAMINE may increase the stimulatory activities of nortriptyline.


hydroxyamphetamine may increase the stimulatory activities of cyclobenzaprine.


Amfepramone may increase the stimulatory activities of protriptyline.


dextroamphetamine may increase the stimulatory activities of Tianeptine.


dextroamphetamine may increase the stimulatory activities of amitriptyline.


Lisdexamfetamine may increase the stimulatory activities of Dothiepin.


hydroxyamphetamine may increase the stimulatory activities of imipramine.


Lisdexamfetamine may increase the stimulatory activities of trimipramine.


hydroxyamphetamine may increase the stimulatory activities of clomipramine.


dextroamphetamine may increase the stimulatory activities of cyclobenzaprine.


AMPHETAMINE may increase the stimulatory activities of amoxapine.


Lisdexamfetamine may increase the stimulatory activities of clomipramine.


AMPHETAMINE may increase the stimulatory activities of trimipramine.


Lisdexamfetamine may increase the stimulatory activities of Tianeptine.


Amfepramone may increase the stimulatory activities of Dothiepin.


AMPHETAMINE may increase the stimulatory activities of protriptyline.


Amfepramone may increase the stimulatory activities of desipramine.


Lisdexamfetamine may increase the stimulatory activities of desipramine.


Zoledronic acid may increase the hypocalcemic activities of paromomycin.


Zoledronic acid may increase the hypocalcemic activities of Spectinomycin.


Zoledronic acid may increase the hypocalcemic activities of doxorubicin.


Risedronic acid may increase the hypocalcemic activities of Amrubicin.


Ibandronic Acid may increase the hypocalcemic activities of IDARUBICIN.


Ibandronic Acid may increase the hypocalcemic activities of kanamycin.


Zoledronic acid may increase the hypocalcemic activities of metrizamide.


Tiludronic Acid may increase the hypocalcemic activities of ribostamycin.


Tiludronic Acid may increase the hypocalcemic activities of Valrubicin.


Risedronic acid may increase the hypocalcemic activities of Epirubicin.


Cis-mdp may increase the hypocalcemic activities of Arbekacin.


ALENDRONIC ACID may increase the hypocalcemic activities of Spectinomycin.


Risedronic acid may increase the hypocalcemic activities of Spectinomycin.


Ibandronic Acid may increase the hypocalcemic activities of amikacin.


Zoledronic acid may increase the hypocalcemic activities of streptozocin.


ALENDRONIC ACID may increase the hypocalcemic activities of doxorubicin.


Zoledronic acid may increase the hypocalcemic activities of plicamycin.


Zoledronic acid may increase the hypocalcemic activities of gentamicin.


Ibandronic Acid may increase the hypocalcemic activities of metrizamide.


PAMIDRONIC ACID may increase the hypocalcemic activities of daunorubicin.


Cis-mdp may increase the hypocalcemic activities of Spectinomycin.


ALENDRONIC ACID may increase the hypocalcemic activities of kanamycin.


ALENDRONIC ACID may increase the hypocalcemic activities of IDARUBICIN.


Etidronic acid may increase the hypocalcemic activities of gentamicin.


Risedronic acid may increase the hypocalcemic activities of plicamycin.


Etidronic acid may increase the hypocalcemic activities of ribostamycin.


Etidronic acid may increase the hypocalcemic activities of netilmicin.


Ibandronic Acid may increase the hypocalcemic activities of ribostamycin.


Cis-mdp may increase the hypocalcemic activities of amikacin.


Tiludronic Acid may increase the hypocalcemic activities of streptomycin.


Ibandronic Acid may increase the hypocalcemic activities of gentamicin.


Tiludronic Acid may increase the hypocalcemic activities of streptozocin.


Etidronic acid may increase the hypocalcemic activities of Epirubicin.


Cis-mdp may increase the hypocalcemic activities of tobramycin.


Cis-mdp may increase the hypocalcemic activities of metrizamide.


Cis-mdp may increase the hypocalcemic activities of kanamycin.


Tiludronic Acid may increase the hypocalcemic activities of Arbekacin.


Cis-mdp may increase the hypocalcemic activities of IDARUBICIN.


Etidronic acid may increase the hypocalcemic activities of Amrubicin.


Risedronic acid may increase the hypocalcemic activities of doxorubicin.


Ibandronic Acid may increase the hypocalcemic activities of Amrubicin.


Risedronic acid may increase the hypocalcemic activities of tobramycin.


Zoledronic acid may increase the hypocalcemic activities of ribostamycin.


Cis-mdp may increase the hypocalcemic activities of daunorubicin.


ALENDRONIC ACID may increase the hypocalcemic activities of tobramycin.


Clodronic Acid may increase the hypocalcemic activities of daunorubicin.


ALENDRONIC ACID may increase the hypocalcemic activities of Epirubicin.


Clodronic Acid may increase the hypocalcemic activities of Amrubicin.


Clodronic Acid may increase the hypocalcemic activities of ribostamycin.


PAMIDRONIC ACID may increase the hypocalcemic activities of Arbekacin.


PAMIDRONIC ACID may increase the hypocalcemic activities of amikacin.


Ibandronic Acid may increase the hypocalcemic activities of Valrubicin.


Tiludronic Acid may increase the hypocalcemic activities of kanamycin.


Clodronic Acid may increase the hypocalcemic activities of paromomycin.


Risedronic acid may increase the hypocalcemic activities of amikacin.


Cis-mdp may increase the hypocalcemic activities of streptomycin.


Cis-mdp may increase the hypocalcemic activities of Epirubicin.


PAMIDRONIC ACID may increase the hypocalcemic activities of metrizamide.


Zoledronic acid may increase the hypocalcemic activities of streptomycin.


Etidronic acid may increase the hypocalcemic activities of streptomycin.


ALENDRONIC ACID may increase the hypocalcemic activities of amikacin.


Clodronic Acid may increase the hypocalcemic activities of Epirubicin.


Clodronic Acid may increase the hypocalcemic activities of tobramycin.


Risedronic acid may increase the hypocalcemic activities of daunorubicin.


Risedronic acid may increase the hypocalcemic activities of paromomycin.


Tiludronic Acid may increase the hypocalcemic activities of plicamycin.


ALENDRONIC ACID may increase the hypocalcemic activities of metrizamide.


Risedronic acid may increase the hypocalcemic activities of kanamycin.


Clodronic Acid may increase the hypocalcemic activities of plicamycin.


Risedronic acid may increase the hypocalcemic activities of IDARUBICIN.


Tiludronic Acid may increase the hypocalcemic activities of Epirubicin.


ALENDRONIC ACID may increase the hypocalcemic activities of plicamycin.


Etidronic acid may increase the hypocalcemic activities of streptozocin.


Cis-mdp may increase the hypocalcemic activities of Valrubicin.


Ibandronic Acid may increase the hypocalcemic activities of streptomycin.


Tiludronic Acid may increase the hypocalcemic activities of paromomycin.


Tiludronic Acid may increase the hypocalcemic activities of tobramycin.


Etidronic acid may increase the hypocalcemic activities of paromomycin.


Clodronic Acid may increase the hypocalcemic activities of Arbekacin.


Etidronic acid may increase the hypocalcemic activities of Valrubicin.


Tiludronic Acid may increase the hypocalcemic activities of netilmicin.


ALENDRONIC ACID may increase the hypocalcemic activities of Amrubicin.


Zoledronic acid may increase the hypocalcemic activities of amikacin.


Zoledronic acid may increase the hypocalcemic activities of Valrubicin.


PAMIDRONIC ACID may increase the hypocalcemic activities of IDARUBICIN.


Ibandronic Acid may increase the hypocalcemic activities of streptozocin.


PAMIDRONIC ACID may increase the hypocalcemic activities of kanamycin.


ALENDRONIC ACID may increase the hypocalcemic activities of streptomycin.


Cis-mdp may increase the hypocalcemic activities of paromomycin.


Zoledronic acid may increase the hypocalcemic activities of netilmicin.


ALENDRONIC ACID may increase the hypocalcemic activities of gentamicin.


Clodronic Acid may increase the hypocalcemic activities of doxorubicin.


Risedronic acid may increase the hypocalcemic activities of metrizamide.


Risedronic acid may increase the hypocalcemic activities of Arbekacin.


ALENDRONIC ACID may increase the hypocalcemic activities of netilmicin.


Tiludronic Acid may increase the hypocalcemic activities of daunorubicin.


PAMIDRONIC ACID may increase the hypocalcemic activities of tobramycin.


PAMIDRONIC ACID may increase the hypocalcemic activities of plicamycin.


Ibandronic Acid may increase the hypocalcemic activities of tobramycin.


ALENDRONIC ACID may increase the hypocalcemic activities of daunorubicin.


Cis-mdp may increase the hypocalcemic activities of gentamicin.


Tiludronic Acid may increase the hypocalcemic activities of Spectinomycin.


PAMIDRONIC ACID may increase the hypocalcemic activities of netilmicin.


ALENDRONIC ACID may increase the hypocalcemic activities of Valrubicin.


PAMIDRONIC ACID may increase the hypocalcemic activities of gentamicin.


Ibandronic Acid may increase the hypocalcemic activities of Arbekacin.


PAMIDRONIC ACID may increase the hypocalcemic activities of streptomycin.


Clodronic Acid may increase the hypocalcemic activities of streptozocin.


Cis-mdp may increase the hypocalcemic activities of netilmicin.


Risedronic acid may increase the hypocalcemic activities of netilmicin.


Ibandronic Acid may increase the hypocalcemic activities of plicamycin.


Clodronic Acid may increase the hypocalcemic activities of kanamycin.


ALENDRONIC ACID may increase the hypocalcemic activities of ribostamycin.


PAMIDRONIC ACID may increase the hypocalcemic activities of streptozocin.


PAMIDRONIC ACID may increase the hypocalcemic activities of Amrubicin.


Etidronic acid may increase the hypocalcemic activities of daunorubicin.


Etidronic acid may increase the hypocalcemic activities of kanamycin.


Etidronic acid may increase the hypocalcemic activities of metrizamide.


Etidronic acid may increase the hypocalcemic activities of IDARUBICIN.


Risedronic acid may increase the hypocalcemic activities of gentamicin.


Ibandronic Acid may increase the hypocalcemic activities of daunorubicin.


Etidronic acid may increase the hypocalcemic activities of Spectinomycin.


Zoledronic acid may increase the hypocalcemic activities of IDARUBICIN.


ALENDRONIC ACID may increase the hypocalcemic activities of paromomycin.


Zoledronic acid may increase the hypocalcemic activities of daunorubicin.


Ibandronic Acid may increase the hypocalcemic activities of Spectinomycin.


Cis-mdp may increase the hypocalcemic activities of ribostamycin.


Etidronic acid may increase the hypocalcemic activities of doxorubicin.


Clodronic Acid may increase the hypocalcemic activities of metrizamide.


Ibandronic Acid may increase the hypocalcemic activities of Epirubicin.


PAMIDRONIC ACID may increase the hypocalcemic activities of Valrubicin.


Clodronic Acid may increase the hypocalcemic activities of Valrubicin.


Zoledronic acid may increase the hypocalcemic activities of kanamycin.


Risedronic acid may increase the hypocalcemic activities of streptomycin.


Clodronic Acid may increase the hypocalcemic activities of gentamicin.


Clodronic Acid may increase the hypocalcemic activities of Spectinomycin.


Cis-mdp may increase the hypocalcemic activities of streptozocin.


Cis-mdp may increase the hypocalcemic activities of Amrubicin.


PAMIDRONIC ACID may increase the hypocalcemic activities of ribostamycin.


Tiludronic Acid may increase the hypocalcemic activities of amikacin.


Etidronic acid may increase the hypocalcemic activities of tobramycin.


Clodronic Acid may increase the hypocalcemic activities of IDARUBICIN.


Cis-mdp may increase the hypocalcemic activities of plicamycin.


Risedronic acid may increase the hypocalcemic activities of streptozocin.


Clodronic Acid may increase the hypocalcemic activities of netilmicin.


Ibandronic Acid may increase the hypocalcemic activities of doxorubicin.


Tiludronic Acid may increase the hypocalcemic activities of Amrubicin.


Zoledronic acid may increase the hypocalcemic activities of Epirubicin.


Zoledronic acid may increase the hypocalcemic activities of tobramycin.


Etidronic acid may increase the hypocalcemic activities of Arbekacin.


Risedronic acid may increase the hypocalcemic activities of Valrubicin.


Etidronic acid may increase the hypocalcemic activities of amikacin.


Zoledronic acid may increase the hypocalcemic activities of Amrubicin.


Zoledronic acid may increase the hypocalcemic activities of Arbekacin.


PAMIDRONIC ACID may increase the hypocalcemic activities of Spectinomycin.


PAMIDRONIC ACID may increase the hypocalcemic activities of paromomycin.


Cis-mdp may increase the hypocalcemic activities of doxorubicin.


Tiludronic Acid may increase the hypocalcemic activities of gentamicin.


PAMIDRONIC ACID may increase the hypocalcemic activities of Epirubicin.


ALENDRONIC ACID may increase the hypocalcemic activities of Arbekacin.


Tiludronic Acid may increase the hypocalcemic activities of metrizamide.


PAMIDRONIC ACID may increase the hypocalcemic activities of doxorubicin.


Ibandronic Acid may increase the hypocalcemic activities of paromomycin.


Ibandronic Acid may increase the hypocalcemic activities of netilmicin.


ALENDRONIC ACID may increase the hypocalcemic activities of streptozocin.


Tiludronic Acid may increase the hypocalcemic activities of doxorubicin.


Clodronic Acid may increase the hypocalcemic activities of amikacin.


Clodronic Acid may increase the hypocalcemic activities of streptomycin.


Risedronic acid may increase the hypocalcemic activities of ribostamycin.


Etidronic acid may increase the hypocalcemic activities of plicamycin.


Tiludronic Acid may increase the hypocalcemic activities of IDARUBICIN.


levonordefrin may increase the atrioventricular blocking (AV block) activities of propranolol.


apomorphine may increase the atrioventricular blocking (AV block) activities of timolol.


norepinephrine may increase the atrioventricular blocking (AV block) activities of timolol.


apomorphine may increase the atrioventricular blocking (AV block) activities of nadolol.


dipivefrin may increase the atrioventricular blocking (AV block) activities of propranolol.


Bethanidine may increase the atrioventricular blocking (AV block) activities of carvedilol.


benzphetamine may increase the atrioventricular blocking (AV block) activities of Arotinolol.


epinephrine may increase the atrioventricular blocking (AV block) activities of Nebivolol.


epinephrine may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


Bethanidine may increase the atrioventricular blocking (AV block) activities of celiprolol.


droxidopa may increase the atrioventricular blocking (AV block) activities of BOPINDOLOL.


xylometazoline may increase the atrioventricular blocking (AV block) activities of oxprenolol.


dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bevantolol.


dihydroergotamine may increase the atrioventricular blocking (AV block) activities of practolol.


ropinirole may increase the atrioventricular blocking (AV block) activities of timolol.


apomorphine may increase the atrioventricular blocking (AV block) activities of Bevantolol.


apomorphine may increase the atrioventricular blocking (AV block) activities of practolol.


Etomidate may increase the atrioventricular blocking (AV block) activities of Nebivolol.


ropinirole may increase the atrioventricular blocking (AV block) activities of betaxolol.


ERGOTAMINE may increase the atrioventricular blocking (AV block) activities of oxprenolol.


dipivefrin may increase the atrioventricular blocking (AV block) activities of sotalol.


clonidine may increase the atrioventricular blocking (AV block) activities of Bevantolol.


clonidine may increase the atrioventricular blocking (AV block) activities of practolol.


xylometazoline may increase the atrioventricular blocking (AV block) activities of BISOPROLOL.


bromocriptine may increase the atrioventricular blocking (AV block) activities of acebutolol.


dipivefrin may increase the atrioventricular blocking (AV block) activities of Bevantolol.


dipivefrin may increase the atrioventricular blocking (AV block) activities of practolol.


dipivefrin may increase the atrioventricular blocking (AV block) activities of penbutolol.


pergolide may increase the atrioventricular blocking (AV block) activities of labetalol.


levonordefrin may increase the atrioventricular blocking (AV block) activities of timolol.


naphazoline may increase the atrioventricular blocking (AV block) activities of carvedilol.


apomorphine may increase the atrioventricular blocking (AV block) activities of propranolol.


ERGOTAMINE may increase the atrioventricular blocking (AV block) activities of Bevantolol.


Etomidate may increase the atrioventricular blocking (AV block) activities of propranolol.


Lofexidine may increase the atrioventricular blocking (AV block) activities of timolol.


dipivefrin may increase the atrioventricular blocking (AV block) activities of acebutolol.


DEXMEDETOMIDINE may increase the atrioventricular blocking (AV block) activities of alprenolol.


tizanidine may increase the atrioventricular blocking (AV block) activities of labetalol.


Etomidate may increase the atrioventricular blocking (AV block) activities of timolol.


bromocriptine may increase the atrioventricular blocking (AV block) activities of alprenolol.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of atenolol.


ropinirole may increase the atrioventricular blocking (AV block) activities of alprenolol.


Etomidate may increase the atrioventricular blocking (AV block) activities of Arotinolol.


pergolide may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


MOXONIDINE may increase the atrioventricular blocking (AV block) activities of propranolol.


levonordefrin may increase the atrioventricular blocking (AV block) activities of betaxolol.


DEXMEDETOMIDINE may increase the atrioventricular blocking (AV block) activities of Nebivolol.


Etomidate may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


benzphetamine may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


dihydroergotamine may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


risperidone may increase the atrioventricular blocking (AV block) activities of alprenolol.


levonordefrin may increase the atrioventricular blocking (AV block) activities of BISOPROLOL.


tizanidine may increase the atrioventricular blocking (AV block) activities of ESMOLOL.


bromocriptine may increase the atrioventricular blocking (AV block) activities of labetalol.


norepinephrine may increase the atrioventricular blocking (AV block) activities of betaxolol.


Lofexidine may increase the atrioventricular blocking (AV block) activities of ESMOLOL.


clonidine may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


guanabenz may increase the atrioventricular blocking (AV block) activities of BUPRANOLOL.


Lofexidine may increase the atrioventricular blocking (AV block) activities of propranolol.


clonidine may increase the atrioventricular blocking (AV block) activities of penbutolol.


guanabenz may increase the atrioventricular blocking (AV block) activities of BOPINDOLOL.


levonordefrin may increase the atrioventricular blocking (AV block) activities of Nebivolol.


epinephrine may increase the atrioventricular blocking (AV block) activities of oxprenolol.


bromocriptine may increase the atrioventricular blocking (AV block) activities of metoprolol.


METHAMPHETAMINE may increase the atrioventricular blocking (AV block) activities of oxprenolol.


Paliperidone may increase the atrioventricular blocking (AV block) activities of Bevantolol.


droxidopa may increase the atrioventricular blocking (AV block) activities of sotalol.


Lofexidine may increase the atrioventricular blocking (AV block) activities of labetalol.


Paliperidone may increase the atrioventricular blocking (AV block) activities of BUPRANOLOL.


norepinephrine may increase the atrioventricular blocking (AV block) activities of carvedilol.


Bethanidine may increase the atrioventricular blocking (AV block) activities of timolol.


ERGOTAMINE may increase the atrioventricular blocking (AV block) activities of Nebivolol.


Bethanidine may increase the atrioventricular blocking (AV block) activities of Arotinolol.


METHAMPHETAMINE may increase the atrioventricular blocking (AV block) activities of nadolol.


GUANFACINE may increase the atrioventricular blocking (AV block) activities of betaxolol.


xylometazoline may increase the atrioventricular blocking (AV block) activities of celiprolol.


ERGOTAMINE may increase the atrioventricular blocking (AV block) activities of BISOPROLOL.


MOXONIDINE may increase the atrioventricular blocking (AV block) activities of Arotinolol.


MOXONIDINE may increase the atrioventricular blocking (AV block) activities of penbutolol.


PSEUDOEPHEDRINE may increase the atrioventricular blocking (AV block) activities of Nebivolol.


Lofexidine may increase the atrioventricular blocking (AV block) activities of penbutolol.


Lofexidine may increase the atrioventricular blocking (AV block) activities of oxprenolol.


ropinirole may increase the atrioventricular blocking (AV block) activities of celiprolol.


bromocriptine may increase the atrioventricular blocking (AV block) activities of oxprenolol.


naphazoline may increase the atrioventricular blocking (AV block) activities of Nebivolol.


pergolide may increase the atrioventricular blocking (AV block) activities of ESMOLOL.


droxidopa may increase the atrioventricular blocking (AV block) activities of betaxolol.


tizanidine may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


xylometazoline may increase the atrioventricular blocking (AV block) activities of alprenolol.


epinephrine may increase the atrioventricular blocking (AV block) activities of sotalol.


pergolide may increase the atrioventricular blocking (AV block) activities of Arotinolol.


bromocriptine may increase the atrioventricular blocking (AV block) activities of Bevantolol.


Paliperidone may increase the atrioventricular blocking (AV block) activities of timolol.


Paliperidone may increase the atrioventricular blocking (AV block) activities of nadolol.


naphazoline may increase the atrioventricular blocking (AV block) activities of alprenolol.


MOXONIDINE may increase the atrioventricular blocking (AV block) activities of carvedilol.


naphazoline may increase the atrioventricular blocking (AV block) activities of penbutolol.


dipivefrin may increase the atrioventricular blocking (AV block) activities of Arotinolol.


naphazoline may increase the atrioventricular blocking (AV block) activities of practolol.


naphazoline may increase the atrioventricular blocking (AV block) activities of Bevantolol.


levonordefrin may increase the atrioventricular blocking (AV block) activities of BOPINDOLOL.


Bethanidine may increase the atrioventricular blocking (AV block) activities of acebutolol.


ERGOTAMINE may increase the atrioventricular blocking (AV block) activities of acebutolol.


GUANFACINE may increase the atrioventricular blocking (AV block) activities of celiprolol.


Etomidate may increase the atrioventricular blocking (AV block) activities of nadolol.


levonordefrin may increase the atrioventricular blocking (AV block) activities of penbutolol.


xylometazoline may increase the atrioventricular blocking (AV block) activities of metoprolol.


xylometazoline may increase the atrioventricular blocking (AV block) activities of penbutolol.


METHAMPHETAMINE may increase the atrioventricular blocking (AV block) activities of carvedilol.


clonidine may increase the atrioventricular blocking (AV block) activities of digitoxin.


DEXMEDETOMIDINE may increase the atrioventricular blocking (AV block) activities of BISOPROLOL.


xylometazoline may increase the atrioventricular blocking (AV block) activities of carvedilol.


bromocriptine may increase the atrioventricular blocking (AV block) activities of Nebivolol.


dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Arotinolol.


levonordefrin may increase the atrioventricular blocking (AV block) activities of carvedilol.


clonidine may increase the atrioventricular blocking (AV block) activities of acebutolol.


DEXMEDETOMIDINE may increase the atrioventricular blocking (AV block) activities of acebutolol.


GUANFACINE may increase the atrioventricular blocking (AV block) activities of alprenolol.


METHAMPHETAMINE may increase the atrioventricular blocking (AV block) activities of Bevantolol.


droxidopa may increase the atrioventricular blocking (AV block) activities of nadolol.


METHAMPHETAMINE may increase the atrioventricular blocking (AV block) activities of practolol.


Etomidate may increase the atrioventricular blocking (AV block) activities of atenolol.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of timolol.


apomorphine may increase the atrioventricular blocking (AV block) activities of atenolol.


Paliperidone may increase the atrioventricular blocking (AV block) activities of labetalol.


apomorphine may increase the atrioventricular blocking (AV block) activities of Arotinolol.


droxidopa may increase the atrioventricular blocking (AV block) activities of alprenolol.


norepinephrine may increase the atrioventricular blocking (AV block) activities of atenolol.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of oxprenolol.


dihydroergotamine may increase the atrioventricular blocking (AV block) activities of celiprolol.


Bethanidine may increase the atrioventricular blocking (AV block) activities of ESMOLOL.


guanabenz may increase the atrioventricular blocking (AV block) activities of metoprolol.


risperidone may increase the atrioventricular blocking (AV block) activities of practolol.


risperidone may increase the atrioventricular blocking (AV block) activities of Bevantolol.


clonidine may increase the atrioventricular blocking (AV block) activities of celiprolol.


apomorphine may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of Bevantolol.


VERAPAMIL may increase the atrioventricular blocking (AV block) activities of acetyldigitoxin.


PSEUDOEPHEDRINE may increase the atrioventricular blocking (AV block) activities of metoprolol.


Etomidate may increase the atrioventricular blocking (AV block) activities of betaxolol.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of practolol.


benzphetamine may increase the atrioventricular blocking (AV block) activities of labetalol.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of ESMOLOL.


benzphetamine may increase the atrioventricular blocking (AV block) activities of ESMOLOL.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of propranolol.


DEXMEDETOMIDINE may increase the atrioventricular blocking (AV block) activities of ESMOLOL.


DEXMEDETOMIDINE may increase the atrioventricular blocking (AV block) activities of oxprenolol.


ERGOTAMINE may increase the atrioventricular blocking (AV block) activities of practolol.


GUANFACINE may increase the atrioventricular blocking (AV block) activities of nadolol.


PSEUDOEPHEDRINE may increase the atrioventricular blocking (AV block) activities of alprenolol.


Bethanidine may increase the atrioventricular blocking (AV block) activities of atenolol.


Bethanidine may increase the atrioventricular blocking (AV block) activities of nadolol.


epinephrine may increase the atrioventricular blocking (AV block) activities of carvedilol.


guanabenz may increase the atrioventricular blocking (AV block) activities of betaxolol.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of labetalol.


ERGOTAMINE may increase the atrioventricular blocking (AV block) activities of timolol.


apomorphine may increase the atrioventricular blocking (AV block) activities of labetalol.


Lofexidine may increase the atrioventricular blocking (AV block) activities of Nebivolol.


droxidopa may increase the atrioventricular blocking (AV block) activities of Arotinolol.


bromocriptine may increase the atrioventricular blocking (AV block) activities of BOPINDOLOL.


METHAMPHETAMINE may increase the atrioventricular blocking (AV block) activities of Nebivolol.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of penbutolol.


benzphetamine may increase the atrioventricular blocking (AV block) activities of oxprenolol.


guanabenz may increase the atrioventricular blocking (AV block) activities of sotalol.


Paliperidone may increase the atrioventricular blocking (AV block) activities of atenolol.


dipivefrin may increase the atrioventricular blocking (AV block) activities of metoprolol.


pergolide may increase the atrioventricular blocking (AV block) activities of BUPRANOLOL.


pergolide may increase the atrioventricular blocking (AV block) activities of BOPINDOLOL.


ropinirole may increase the atrioventricular blocking (AV block) activities of penbutolol.


GUANFACINE may increase the atrioventricular blocking (AV block) activities of atenolol.


xylometazoline may increase the atrioventricular blocking (AV block) activities of betaxolol.


dihydroergotamine may increase the atrioventricular blocking (AV block) activities of BISOPROLOL.


bromocriptine may increase the atrioventricular blocking (AV block) activities of timolol.


guanabenz may increase the atrioventricular blocking (AV block) activities of nadolol.


DEXMEDETOMIDINE may increase the atrioventricular blocking (AV block) activities of sotalol.


PSEUDOEPHEDRINE may increase the atrioventricular blocking (AV block) activities of Arotinolol.


MOXONIDINE may increase the atrioventricular blocking (AV block) activities of celiprolol.


ropinirole may increase the atrioventricular blocking (AV block) activities of labetalol.


oxymetazoline may increase the atrioventricular blocking (AV block) activities of acebutolol.


dipivefrin may increase the atrioventricular blocking (AV block) activities of alprenolol.


tizanidine may increase the atrioventricular blocking (AV block) activities of Arotinolol.


tizanidine may increase the atrioventricular blocking (AV block) activities of metoprolol.


benzphetamine may increase the atrioventricular blocking (AV block) activities of nadolol.


ERGOTAMINE may increase the atrioventricular blocking (AV block) activities of ESMOLOL.


droxidopa may increase the atrioventricular blocking (AV block) activities of Nebivolol.


VERAPAMIL may increase the atrioventricular blocking (AV block) activities of ouabain.


dipivefrin may increase the atrioventricular blocking (AV block) activities of celiprolol.


dihydroergotamine may increase the atrioventricular blocking (AV block) activities of carvedilol.


ropinirole may increase the atrioventricular blocking (AV block) activities of ESMOLOL.


GUANFACINE may increase the atrioventricular blocking (AV block) activities of Bevantolol.


guanabenz may increase the atrioventricular blocking (AV block) activities of Bevantolol.


guanabenz may increase the atrioventricular blocking (AV block) activities of practolol.


naphazoline may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


METHAMPHETAMINE may increase the atrioventricular blocking (AV block) activities of CARTEOLOL.


pergolide may increase the atrioventricular blocking (AV block) activities of Bevantolol.


pergolide may increase the atrioventricular blocking (AV block) activities of practolol.


epinephrine may increase the atrioventricular blocking (AV block) activities of Bevantolol.


GUANFACINE may increase the atrioventricular blocking (AV block) activities of oxprenolol.


epinephrine may increase the atrioventricular blocking (AV block) activities of practolol.


epinephrine may increase the atrioventricular blocking (AV block) activities of penbutolol.


epinephrine may increase the atrioventricular blocking (AV block) activities of acebutolol.


norepinephrine may increase the atrioventricular blocking (AV block) activities of BUPRANOLOL.


norepinephrine may increase the atrioventricular blocking (AV block) activities of BOPINDOLOL.


Lofexidine may increase the atrioventricular blocking (AV block) activities of metoprolol.


levonordefrin may increase the atrioventricular blocking (AV block) activities of labetalol.


norepinephrine may increase the atrioventricular blocking (AV block) activities of labetalol.


dihydroergotamine may increase the atrioventricular blocking (AV block) activities of labetalol.


pergolide may increase the atrioventricular blocking (AV block) activities of alprenolol.


VERAPAMIL may increase the atrioventricular blocking (AV block) activities of Dronedarone.


pergolide may increase the atrioventricular blocking (AV block) activities of oxprenolol.


tizanidine may increase the atrioventricular blocking (AV block) activities of carvedilol.


Etomidate may increase the atrioventricular blocking (AV block) activities of metoprolol.


nicotine may increase the atrioventricular blocking (AV block) activities of adenosine.